Global Bioethics Initiative is pleased to announce the election of Dr. Bruce Gelb, M.D., F.A.C.S, as President of the Board of Directors. Dr. Gelb is an Assistant Professor of Surgery at NYU Langone Medical Center, School of Medicine, and the Surgical Director of Renal Transplantation of the NYU Langone Transplant Institute. He also performs liver transplant surgery and is a key member of the Face Transplant team. He has a vested interest in the field of bioethics, especially the ethics of transplantation.
“As a transplant surgeon, bioethics encompasses virtually every aspect of my work. I had the honor of joining GBI’s Board of Directors three years ago and served as the Interim President of the organization since July 2016. It has been an honor to serve as a lecturer in both Manhattan and Dubrovnik schools and symposiums on the ethics of organ transplantation alongside with world experts in various other fields. I am strong supporter of the mission and educational programs of this young organization.”
Since March 2016, he serves as the Chair of the Quality Improvement Committee at the NYU Langone Medical Center and holds an appointment as a Representative of the United Network for Organ Sharing (UNOS) Ethics Committee for a three-year term. Dr. Gelb has received the multiple clinical awards, including: Castle Connolly Top Doctor, New York 2016, NY Top Docs 2015, Super Doctors “Rising Star” 2013 and 2014, and Alpha Omega Alpha Medical Honors Society. He holds board certification in General Surgery and is certified in Liver, Kidney, and Pancreas transplantation, and Living Donor Surgery.
The GBI Board of Directors and Executive Director would like to give special thanks to our immediate past President and GBI Co-Founder, Dr. Charles Debrovner, Clinical Professor of Obstetrics and Gynecology (retired) at the NYU Langone School of Medicine. His unmatched contributions toward the progress of the organization and his steadfast commitment to the goals and mission of GBI have been critical to the early success and direction of the organization. For the past 5 years, Dr. Debrovner had a profound impact on planning, operations, and programming at GBI.
With his extensive experience in medical practice, scholarly publications, and important involvement in the field, Dr. Gelb will undoubtedly be an invaluable asset to the GBI Board of Directors. Click here to read more.